Skip to main content

McAdam, LLC

SEC CIK
0001695490
Latest filing
Aug 4, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by McAdam, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
543
Value
$269.5K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of VRTX by McAdam, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026543$269.5K<0.1%+543NewHolders
Q1 20260$00.0%−569−100.0%Sold outHolders
Q4 2025569$258.0K<0.1%−171−23.1%ReducedHolders
Q3 2025740$289.8K<0.1%+140+23.3%AddedHolders
Q2 2025600$267.1K<0.1%+84+16.3%AddedHolders
Q1 2025516$250.2K<0.1%−1,679−76.5%ReducedHolders
Q4 20242,195$883.9K<0.1%−441−16.7%ReducedHolders
Q3 20242,636$1.23M0.1%+116+4.6%AddedHolders
Q2 20242,520$1.18M0.1%+488+24.0%AddedHolders
Q1 20242,032$849.4K0.1%+35+1.8%AddedHolders
Q4 20231,997$812.6K0.1%−170−7.8%ReducedHolders
Q3 20232,167$753.6K0.1%+4+0.2%AddedHolders
Q2 20232,163$761.2K0.1%−60−2.7%ReducedHolders
Q1 20232,223$700.4K0.1%−731−24.7%ReducedHolders
Q4 20222,954$649.0K0.1%+186+6.7%AddedHolders
Q3 20222,768$801.0K0.1%+5+0.2%AddedHolders
Q2 20222,763$779.0K0.1%−170−5.8%ReducedHolders
Q1 20222,933$765.0K0.1%−21−0.7%ReducedHolders
Q4 20212,954$649.0K0.1%−385−11.5%ReducedHolders
Q3 20213,339$606.0K0.1%+1,419+73.9%AddedHolders
Q2 20211,920$385.0K<0.1%+210+12.3%AddedHolders
Q1 20211,710$367.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.